Exametazime

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Exametazime
Accession Number
DB11179
Description

Exametazime is a diagnostic radiopharmaceutical agent commonly used for the preparation of Tc99m Exametazime injection. It acts as a chelating agent for the radioisotope technetium-99m to form a cationic complex. It is used in the detection of altered regional cerebral perfusion and for the radiolabeling of autologous leukocytes.

Type
Small Molecule
Groups
Approved
Synonyms
  • Exametazima
  • Exametazime
External IDs
  • DL HM-PAO
  • DL-HM-PAO

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
No interactions found.

Products

Purchasing individual compounds or compound libraries for your research?
Learn More
International/Other Brands
Drax Exametazime
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Exametazime HMPAOInjection, powder, lyophilized, for solution1 mg/1IntravenousAnazao Health Corporation2012-07-01Not applicableUS flag
Additional Data Available
  • Application Number
    Application Number
    Available for Purchase

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code
    Available for Purchase

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Exametazime HMPAOExametazime (1 mg/1)Injection, powder, lyophilized, for solutionIntravenousAnazao Health Corporation2012-07-01Not applicableUS flag

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
G29272NCKL
CAS number
105613-48-7
InChI Key
Not Available
InChI
Not Available
IUPAC Name
Not Available
SMILES
Not Available

References

General References
  1. FDA Approved Drug Products: Drax Exametazime (kit for the preparation of technetium Tc99m exametazime for leukocyte labeling) for intravenous use [Link]
PubChem Substance
347911145
RxNav
62153
Wikipedia
Technetium_(99mTc)_exametazime

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3Unknown StatusDiagnosticVascular Prosthesis Infection1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, powder, lyophilized, for solutionIntravenous0.3 mg
Injection, powder, for solutionIntravenous300 mcg
InjectionIntravenous0.5 MG
Injection, powder, for solution
Injection, powder, for solutionParenteral0.5 mg
Injection, powder, lyophilized, for solutionIntravenous0.5 mg
Injection, powder, lyophilized, for solutionIntravenous1 mg/1
Kit500 Mikrogramm
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Not Available
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created on December 03, 2015 09:51 / Updated on September 11, 2020 06:08

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates